EMBC — Embecta Corp. Stock Price, Chart & AI Report

Positive Feb 6, 2026 • 20:15 UTC The Motley Fool • Thomas Niel

3 Healthcare Stocks Paying the Highest Dividends of 2026

The article examines three high-yielding healthcare stocks: Perrigo (8.2% yield) is cautioned as a potential value trap despite strong dividend history; Pfizer (6.7% yield) is viewed more favorably with post-COVID catalysts and GLP-1 product launches; Embecta (5.5% yield) shows turnaround potential as it pivots toward the GLP-1 pen needle business.

PRGO PFE EMBC healthcare stocks dividend yield value trap GLP-1 post-COVID catalysts

Sentiment note

Despite a 37% share price decline over 12 months, the company offers a 5.5% dividend yield and significant rebound potential through expansion into the GLP-1 pen needle business. Trading at less than 7 times forward earnings with moderate organic growth prospects.

Positive Feb 5, 2026 • 11:00 UTC GlobeNewswire Inc. • Na

embecta Announces Quarterly Cash Dividend

Embecta Corp. (Nasdaq: EMBC) announced a quarterly cash dividend of $0.15 per share, payable on March 17, 2026 to shareholders of record as of February 27, 2026. The company continues its operations as a global medical supplies provider focused on insulin delivery solutions.

EMBC dividend cash dividend shareholder returns medical supplies insulin delivery quarterly earnings

Sentiment note

The declaration of a quarterly cash dividend of $0.15 per share demonstrates financial stability and confidence in the company's cash flow generation. Regular dividend payments are typically viewed positively by investors as they indicate profitability and management's commitment to returning value to shareholders.

Neutral Jan 22, 2026 • 22:00 UTC GlobeNewswire Inc. • Na

embecta to Report Fiscal First Quarter Financial Results

Embecta Corp. (NASDAQ: EMBC), a global medical supplies company with a 100-year legacy in insulin delivery, announced it will host a conference call on February 5, 2026, at 8:00 a.m. ET to discuss its fiscal first quarter 2026 financial results and provide an operational update. The live webcast will be accessible via the company's investor relations website.

EMBC Embecta Corp. fiscal Q1 2026 financial results conference call insulin delivery medical supplies

Sentiment note

The article is a routine announcement of an upcoming earnings call and conference presentation. It contains no forward-looking statements, performance metrics, or strategic developments that would indicate positive or negative sentiment. It is purely informational regarding scheduled investor communications.

Neutral Nov 25, 2025 • 11:00 UTC GlobeNewswire Inc. • Na

embecta Announces Quarterly Cash Dividend

Embecta Corp. declared a quarterly cash dividend of $0.15 per share, payable on December 18, 2025. The company also announced board changes, with David J. Albritton resigning and David F. Melcher planning to retire.

EMBC dividend board changes corporate governance

Sentiment note

The announcement contains routine corporate actions like dividend declaration and board transitions, which do not significantly impact the company's perceived performance or outlook

Neutral Nov 17, 2025 • 22:00 UTC GlobeNewswire Inc. • Devdatt Kurdikar

embecta announces changes to Board of Directors

Embecta Corp. announced two board member departures: David J. Albritton resigning immediately and LTG David F. Melcher retiring at the 2026 annual stockholder meeting. The company plans to appoint Dev Kurdikar as Chairman and Dr. Claire Pomeroy as Lead Independent Director.

EMBC board changes leadership transition corporate governance

Sentiment note

The board changes appear to be part of a planned transition, with leadership expressing gratitude and confidence in the company's future direction

Neutral Nov 11, 2025 • 22:00 UTC GlobeNewswire Inc. • Embecta Corp.

embecta to Report Fiscal Fourth Quarter and Full Year 2025 Financial Results

Embecta Corp. will host a conference call on November 25, 2025, at 8:00 a.m. ET to discuss its fiscal fourth quarter and full year 2025 financial results and provide preliminary fiscal year 2026 financial guidance.

EMBC financial results conference call investor update medical supplies

Sentiment note

The article is a standard financial results announcement without indicating significant positive or negative performance indicators

Positive Aug 26, 2025 • 21:00 UTC GlobeNewswire Inc. • Embecta Corp.

embecta to Participate in Investor Events

Embecta Corp. announced participation in two upcoming investor conferences in September 2025, including a fireside session at the Wells Fargo Healthcare Conference and one-on-one investor meetings at the Morgan Stanley Global Healthcare Conference.

EMBC WFC WFCPA WFCPC investor conferences healthcare medical supplies investor meetings

Sentiment note

The company is proactively engaging with investors through conference participation, indicating confidence in its business strategy and growth potential

Positive Aug 8, 2025 • 10:00 UTC GlobeNewswire Inc. • Christian Glazar

embecta Announces Quarterly Cash Dividend

Embecta Corp. announced a quarterly cash dividend of $0.15 per share, payable on September 15, 2025, to stockholders of record as of August 29, 2025.

EMBC dividend quarterly stockholders cash dividend

Sentiment note

Company is declaring a consistent cash dividend, which signals financial stability and commitment to shareholder value

Neutral Jul 24, 2025 • 21:00 UTC GlobeNewswire Inc. • Na

embecta to Report Fiscal Third Quarter 2025 Financial Results

Embecta Corp. will host a conference call on August 8, 2025, at 8:00 a.m. ET to discuss its fiscal third quarter 2025 financial results and provide an operational update.

EMBC financial results conference call investor relations medical supplies

Sentiment note

The article is a standard financial conference call announcement with no explicit positive or negative indicators, presenting routine corporate communication about upcoming financial reporting

Neutral May 27, 2025 • 21:00 UTC GlobeNewswire Inc. • N/A

embecta to Participate in Investor Events

Embecta Corp., a global diabetes care company, reported its financial results for the second quarter of fiscal 2025. The company also announced its participation in various investor events.

EMBC Embecta Corp. financial results investor events

Sentiment note

The article provides financial results and upcoming investor events, which are neutral in nature and do not indicate a strong positive or negative sentiment.

Positive May 9, 2025 • 10:00 UTC GlobeNewswire Inc. • N/A

embecta Announces Quarterly Cash Dividend

Embecta Corp. (EMBC) has declared a quarterly cash dividend of $0.15 per share, payable on June 13, 2025 to stockholders of record as of May 28, 2025.

EMBC dividend quarterly cash dividend Embecta Corp.

Sentiment note

The company has declared a quarterly cash dividend, which is a positive sign for shareholders and indicates the company's financial stability and commitment to returning value to its investors.

Neutral Apr 21, 2025 • 21:00 UTC GlobeNewswire Inc. • N/A

embecta to Report Fiscal Second Quarter 2025 Financial Results

embecta Corp., a global diabetes care company, will host a conference call to discuss its fiscal second quarter 2025 financial results and provide an operational update on May 9, 2025.

EMBC embecta earnings call financial results operational update

Sentiment note

The article provides factual information about embecta's upcoming earnings call and does not indicate any positive or negative sentiment towards the company.